A groundbreaking text for occupational therapists, Adaptation, Coping, and Resilience in Children and Youth: A Comprehensive Occupational Therapy Approach offers a different perspective in addressing the ways children and youth with a variety of conditions and personal contexts can have more optimized participation in everyday life. This text is essential for occupational therapy graduate students, instructors, and pediatric clinicians. Drs. Lenin C. Grajo and Angela K. Boisselle provide a comprehensive, strength-based approach in addressing the ability of children to adjust to a variety of challenges encountered in daily life across multiple environments and contexts. Adaptation, Coping, and Resilience in Children and Youth includes best and evidence-based practices for assessment and intervention. Included in the book: Collaborative approach with families How to build relationships through interprofessional collaboration (teachers, health care team, and community) Global perspectives of adaptation, coping, and resilience Case applications and essential considerations for occupational therapists The text also covers underexplored contexts such as those who have been bullied, children and youth who are LGBTQ and gender expansive, children and youth of color, those who live as a member of a migrant family, and those who have lived with and through adverse childhood experiences. Adaptation, Coping, and Resilience in Children and Youth: A Comprehensive Occupational Therapy Approach is a necessary text that offers timely best and evidence-based practices for assessment and intervention for occupational therapy students and professionals.

Navigating the teen years with Type 1 diabetes can be difficult. This guide will help parents and teens make the journey much more pleasant - and even an enjoyable experience.

This accessibly written book provides a broad introduction to diabetes—its signs, symptoms, and effects on the body; how it can be managed and prevented; and the issues and controversies that surround this all-too-common condition. Today, nearly one in 10 Americans has diabetes, and complications from diabetes are now the seventh leading cause of death in the United States. Rates of type 2 diabetes are on the rise, despite the fact that it's considered a highly preventable condition. What You Need to Know about Diabetes is a part of Greenwood's Inside Diseases and Disorders series. This series profiles a variety of physical and psychological conditions, distilling and consolidating vast collections of scientific knowledge into concise, readable volumes. A list of "top 10" essential questions begins each book, providing quick-access answers to readers' most pressing concerns. The text follows a standardized, easy-to-navigate structure, with each chapter exploring a particular facet of the topic. In addition to covering basics such as causes, signs and symptoms, diagnosis, and management options, books in this series delve into issues that are less commonly addressed but still critically important, such as effects on loved ones and caregivers. Case illustrations highlight key themes discussed in the book and are accompanied by insightful analyses and recommendations.

This two volume set LNBI 10813 and LNBI 10814 constitutes the proceedings of the 6th International Work-Conference on Bioinformatics and Biomedical Engineering, IWBBIO 2018, held in Granada, Spain, in April 2018.The 88 regular papers presented were carefully reviewed and selected from 273 submissions. The scope of the conference spans the following areas: bioinformatics for healthcare and diseases; bioinformatics tools to integrate omics dataset and address biological question; challenges and advances in measurement and self-parametrization of complex biological systems; computational genomics; computational proteomics; computational systems for modelling biological processes; drug delivery system design aided by mathematical modelling and experiments; generation, management and biological insights from big data; high-throughput bioinformatic tools for medical genomics; next generation sequencing and sequence analysis; interpretable models in biomedicine and bioinformatics; little-big data. Reducing the complexity and facing uncertainty of highly underdetermined phenotype prediction problems; biomedical engineering; biomedical image analysis; biomedical signal analysis; challenges in smart and wearable sensor design for mobile health; and healthcare and diseases.

The Type 1 Diabetes Self-Care Manual: A Complete Guide to Type 1 Diabetes Across the Lifespan for People with Diabetes, Parents, and Caregivers offers practical, evidence-based and common sense help for people with type 1 diabetes and their caregivers. For the close to 1.5 million people with type 1 diabetes in the United States alone and their family and friends, this book will help them understand the effects of type 1 diabetes, not just when diagnosed, but throughout their lifespan. Dr. Jamie Wood and Dr. Anne Peters, two of the most respected and sought-after endocrinologists, provide an easy-to-follow narrative on all aspects of the disease. The Type 1 Diabetes Self-Care Manual will be the go-to reference for everyone touched by type 1 diabetes.

The American Diabetes Association/JDRF Type 1 Diabetes Sourcebook serves as both an evidence-based reference work and consensus report outlining the most critical components of care for individuals with type 1 diabetes throughout their lifespan. The volume serves not only as a comprehensive guide for clinicians, but also reviews the evidence supporting these components of care and provides a perspective on the critical areas of research that are needed to improve our understanding of type 1 diabetes diagnosis and treatment. The volume focuses specifically on the needs of patients with type 1 diabetes and provides clear and detailed guidance on the current standards for the optimal treatment of type 1 diabetes from early childhood to later life. To accomplish the book’s editorial goals, Editors-in-Chief, Drs. Anne Peters and Lori Laffel, assembled an editorial steering committee of prominent research physicians, clinicians, and educators to develop the topical coverage. In addition, a Managing Editor was brought on to help the authors write and focus their chapters.

This book provides a broad overview of rare disease drug development. It offers unique insights from various perspectives, including third-party capital providers, caregivers, patient advocacy groups, drug development professionals, marketing and commercial experts, and patients. A unique reference, the book begins with narratives on the many challenges faced by rare disease patient and their caregivers. Subsequent chapters underscore the critical, multidimensional role of patient advocacy groups and the novel approaches to related clinical trials, investment decisions, and the optimization of rare disease registries. The book addresses various rare disease drug development processes by disciplines such as oncology, hematology, pediatrics, and gene therapy. Chapters then address the operational aspects of drug development, including approval processes, development accelerations, and market access strategies. The book concludes with reflections on the authors' case for real-world data and evidence generation in orphan medicinal drug development. Rare Disease Drug Development is an expertly written text optimized for biopharmaceutical R&D experts, commercial experts, third-party capital providers, patient advocacy groups, patients, and caregivers.